Viewing StudyNCT02729025



Ignite Creation Date: 2024-05-06 @ 8:21 AM
Last Modification Date: 2024-10-26 @ 11:59 AM
Study NCT ID: NCT02729025
Status: COMPLETED
Last Update Posted: 2022-09-23
First Post: 2016-03-08

Brief Title: Effects of Proprotein Convertase SubtilisinKexin Type 9 PCSK9 Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoproteina Lpa
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Subjects With Hyperlipidemia Dyslipidemia
Keywords:
Name View
Hyperlipidemia View
Dyslipidemia View
Proprotein convertase subtilisinkexin type 9 PCSK9 Inhibition View
Arterial Wall Inflamation View
Elevated lipoprotein a View